Clinical Outcomes According to Genomic Abnormalities in 566 Newly Diagnosed Multiple Myeloma Patients Treated with Bortezomib-Based Regimens

M. CAVO;S. BRINGHEN;N. TESTONI;P. OMEDÈ;G. MARZOCCHI;M. RUGGERI;S. DURANTE;DI RAIMONDO, FRANCESCO;D. ROSSI;A. GORGONE;F. PATRIARCA;M. T. PETRUCCI;S. BUTTIGNOL;A. LEVI;M. OFFIDANI;C. NOZZOLI;R. RIA;B. OLIVERO;M. GALLI;V. MONTEFUSCO;V. CALLEA;A. FALCONE;A. DE VIVO;M. BOCCADORO;C. TERRAGNA;AND A. PALUMBO

2009-01-01